Proportions of liver CD4+ T cells (Figure S8A), CD23+ B cells (Figure S8B), SiglecF+CD11b+ eosinophils (Figure S8C), Lin-T1/ST2+ ILC2 (Figure S8D) and F4/80+CD11b+ inflammatory macrophages (Figure S8E) were significantly reduced (p<0.05), and consistently so over the third infection & treatment cycle. This evidence concerns the gene CD4 and infection.